SEARCH HEALTH CONDITIONS BY ALPHABETS

Paragonimus Westermani, Lung Fluke



Medications for Paragonimus westermani, Lung Fluke

Around Paragonimus westermani, Lung Fluke:  The lung fluke is located mostly in Japan, Korea, Taiwan, China, the Philippines, and Thailand. Miracidia interrupts Melania snails, also produce massive amounts of cercariae that render the snail and crawl in to viscera and muscles of both crayfish or crabs and encyst. In humans the excysted rats migrate through the diaphragm into the lungs and invade the walls of the gut.

Drugs Used to Treat Paragonimus westermani, Lung Fluke

This listing of medications come utilized in the treating this particular condition, or somehow associated with.

Drug title Rx / OTC Pregnancy CSA AlcoholReviewsRatingPopularity
BiltricideRx B N Add inspection
0.0

Generic name: praziquantel systemic

Drug class: anthelmintics

For customers: dosage, interactions, side effects

For specialists: AHFS DI Monograph, Prescribing Information

praziquantelRx B N Inch  inspection
7.0

Generic name: praziquantel systemic

Brand name:  Biltricide

Drug class: anthelmintics

For customers: dosage, interactions,

For specialists: a Z Medication Truth, AHFS DI Monograph, Prescribing Information

Legend

RxPrescription-only
OTCOn The Counter
Rx/OTCPrescription or Over The Counter
Off LabelThis medicine may not be approved by the FDA for treating this ailment.
Pregnancy Category
AAdequate and well-controlled studies have failed to demonstrate a risk to the embryo in the first trimester of pregnancy (also there is no evidence of risk in later trimesters).
BAnimal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in elderly women.
CAnimal research studies have demonstrated an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but possible benefits may warrant use in pregnant women despite potential risks.
DThere is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but possible benefits may justify use in pregnant women despite potential risks.
XStudies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved with use in elderly women clearly outweigh potential benefits.
NFDA have not classified this medication.
Controlled Substances Act (CSA) Schedule
NIs not at the mercy of the Controlled Substances Act.
Inch features a high possibility of misuse. Has no accepted medical use in treatment in the USA. There is a lack of accepted safety for use under medical supervision.
Two features a high possibility of misuse. Has a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the USA. Abuse may result in severe physical or psychological dependency.
3Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the USA. Abuse may lead to physical dependence or high psychological dependence.
4features a minimal potential for abuse in accordance with people in schedule 3. It has a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5features a minimal potential for abuse in accordance with those in schedule 4. Has a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence.
Infection
XInteracts with Medication.

Browse Treatment Plans

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • that I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Further information

Always consult your healthcare provider to ensure the information displayed on these pages applies to your circumstances.



Top USA Pharma Companies